Ray Dalio
HRMY icon

Ray Dalio’s Harmony Biosciences HRMY Stock Holding History

Ray Dalio’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.04M Buy
251,506
+22,992
+10% +$754K 0.03% 340
2025
Q4 		$8.55M Buy
228,514
+16,988
+8% +$559K 0.03% 398
2025
Q3 		$5.83M Buy
+211,526
New +$7.29M 0.02% 457

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Ray Dalio's HRMY Position: Q1 2026 in Review

Ray Dalio increased its Harmony Biosciences (HRMY) stake by 10% in Q1 2026, buying an estimated $754K and bringing the position to 251,506 shares worth $7.04M. The position accounts for 0.03% of the portfolio, ranked #340.

Ray Dalio first reported a position in HRMY in Q3 2025 and has held it in 3 quarters since. The position peaked at $8.55M in Q4 2025. 310 funds tracked by Wall St. Rank hold HRMY as of Q1 2026.

  • Ray Dalio held 251,506 shares of Harmony Biosciences worth $7.04M as of Q1 2026.
  • Ray Dalio bought 22,992 Harmony Biosciences shares in Q1 2026, an estimated $754K.
  • Harmony Biosciences made up 0.03% of Ray Dalio's portfolio in Q1 2026, its #340 holding.
  • Ray Dalio first reported a position in Harmony Biosciences in Q3 2025 and has held it in 3 quarters since.
  • Ray Dalio's Harmony Biosciences position peaked at $8.55M in Q4 2025.
  • 310 funds tracked by Wall St. Rank held Harmony Biosciences as of Q1 2026.

Based on Bridgewater Associates's 13F filing for Q1 2026, filed 15 May 2026.